<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03287388</url>
  </required_header>
  <id_info>
    <org_study_id>63227.091.17</org_study_id>
    <nct_id>NCT03287388</nct_id>
  </id_info>
  <brief_title>MRI Measurement of the Effects of Deep Neuromuscular Blockade on the Abdominal Working Space During Laparoscopy</brief_title>
  <acronym>RELAX-2</acronym>
  <official_title>MRI Measurement of the Effects of Moderate Versus Deep Neuromuscular Blockade on the Abdominal Working Space During Laparoscopic Surgery in a Prospective Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During laparoscopy, a surgical working space is obtained by creation of a pneumoperitoneum.
      Optimal surgical conditions are essential to ensure the patient's safety. A meta-analysis on
      studies comparing the influence of deep and moderate neuromuscular blockade (NMB) on the
      quality of the surgical space conditions during laparoscopy (1), showed that compared to
      moderate NMB, deep neuromuscular blockade improves the surgical space conditions, assessed by
      the Leiden-Surgical Rating scale, as reported by Martini and colleagues (2).

      In this prospective cohort study, we will assess the influence of deep neuromuscular blockade
      on the surgical space, measured by magnetic resonance imaging (MRI) in patients scheduled for
      laparoscopic donor nephrectomy, laparoscopic cholecystectomy or laparoscopic colectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To establish the influence of deep neuromuscular blockade (NMB) on the abdominal
      working space during laparoscopy.

      Study design: A single center prospective cohort study

      Study population: 8 adult patients (18 years or older), equally distributed by gender,
      scheduled for laparoscopic donor nephrectomy, laparoscopic cholecystectomy or laparoscopic
      colectomy.

      Study procedures:

      Induction of general anesthesia followed by intubation and creation of a pneumoperitoneum (12
      mmHg).

      Each patient will have a MRI scan during 3 stages:

      Phase 1: No neuromuscular blockade (TOF ratio 1) Phase 2: moderate neuromuscular blockade(TOF
      1-3). Phase 3: deep neuromuscular blockade (PTC 0-1)

      Primary outcome:

      The abdominal space measured by MRI: Skin - sacral promontory distance

      Secondary outcome:

      3D volume measurement of the abdominal cavity by MRI.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Each patient wil serve as its own control:
Each patient will start without neuromuscular blockade (phase 1), followed by moderate neuromuscular blockade (phase 2) and deep neuromuscular blockade (phase 3).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abdominal working space</measure>
    <time_frame>3 times (phase 1 (no neuromuscular blockade, phase 2 moderate neuromuscular blockade, phase 3 deep neuromuscular blockade. From start of surgery until third scan, total duration of 30 minutes</time_frame>
    <description>Skin-sacral promontory distance, measured by MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Abdominal volume</measure>
    <time_frame>3 times (phase 1 no neuromuscular blockade, phase 2 moderate neuromuscular blockade, phase 3 deep neuromuscular blockade. From start of surgery until third scan, total duration of 30 minutes</time_frame>
    <description>3D volume abdominal cavity, measured by MRI</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Neuromuscular Block</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>No Rocuronium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phase 1: no neuromuscular blockade</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium (moderate NMB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phase 2: moderate neuromuscular blockade (TOF 1-3)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium (deep NMB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phase 3: deep neuromuscular blockade (PTC 0-1)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No Rocuronium</intervention_name>
    <description>Phase 1: The patient will undergo a routine MRI-abdomen without neuromuscular blockade: TOF ratio =1.</description>
    <arm_group_label>No Rocuronium</arm_group_label>
    <other_name>No neuromuscular blockade</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium (moderate NMB)</intervention_name>
    <description>Phase 2: Rocuronium will be titrated to a moderate NMB (TOF 1-3), monitored by TOF-watch. When an adequate moderate NMB is achieved, the patient will undergo a second MRI-abdomen.</description>
    <arm_group_label>Rocuronium (moderate NMB)</arm_group_label>
    <other_name>Moderate neuromuscular blockade (Rocuronium)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium (deep NMB)</intervention_name>
    <description>Phase 3: The patient receives a bolus of 1.2 mg/kg rocuronium (adjusted to ideal body weight), to assure a deep or intense NMB (PTC 0-1). Then the patient will undergo the final, third MRI scan of the abdomen.</description>
    <arm_group_label>Rocuronium (deep NMB)</arm_group_label>
    <other_name>Deep neuromuscular blockade (Rocuronium)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for laparoscopic donor nephrectomy, laparoscopic cholecystectomy or
             laparoscopic colectomy

          -  obtained informed consent

        Exclusion Criteria:

          -  Unable to provide informed consent

          -  known or suspect allergy to mivacurium, rocuronium or sugammadex

          -  neuromuscular disease

          -  indication for rapid sequence induction

          -  Being unable to undergo MRI due to any reason (e.g. non MRI-compatible implants,
             epilepsy)

          -  BMI&gt;30 kg/m2

          -  American Society of Anesthesiologists (ASA) classification &gt;2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michiel C Warlé, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Moira HD Bruintjes, Msc.</last_name>
    <phone>(+)31-24-3617612</phone>
    <email>Moira.Bruintjes@radboudumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Piet Krijtenburg, Drs.</last_name>
    <phone>(+)31-24-3619032</phone>
    <email>Piet.Krijtenburg@radboudumc.nl</email>
  </overall_contact_backup>
  <reference>
    <citation>Bruintjes MH, van Helden EV, Braat AE, Dahan A, Scheffer GJ, van Laarhoven CJ, Warlé MC. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth. 2017 Jun 1;118(6):834-842. doi: 10.1093/bja/aex116.</citation>
    <PMID>28575335</PMID>
  </reference>
  <reference>
    <citation>Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014 Mar;112(3):498-505. doi: 10.1093/bja/aet377. Epub 2013 Nov 15.</citation>
    <PMID>24240315</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2017</study_first_submitted>
  <study_first_submitted_qc>September 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2017</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Abdominal working space</keyword>
  <keyword>Moderate neuromuscular blockade</keyword>
  <keyword>Deep neuromuscular blockade</keyword>
  <keyword>MRI measurement</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

